Skip to main content
SpringerLink
Log in

Antidepressiva

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

  • 4105 Accesses

Zusammenfassung

Antidepressiva sind eine heterogene Gruppe von Pharmaka, die bei depressiven Syndromen unterschiedlicher nosologischer Zuordnung und Charakteristik einen stimmungsaufhellenden und/oder antriebsverbessernden Therapieeffekt haben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Banerjee S, Hellier J, Dewey M et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378(9789): 403–411

    Article  PubMed  CAS  Google Scholar 

  • Barbee JG, Thompson TR, Jamhour NJ et al (2011) A double-blind placebo-controlled trial of I amotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. J Clin Psychiatry 72(10): 1405–1412

    Article  Google Scholar 

  • Barbui C, Esposito E, Cipriani A (2009) Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 180(3): 291–297

    Google Scholar 

  • Barbui C, Cipriani A, Patel V et al (2011) Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198(1) (Suppl 1): 11–16

    Article  PubMed  Google Scholar 

  • Baumeister H, Hutter N, Bengel J (2011) Psychological and pharmacological interventions for depression in patients with oronary artery disease. Cochrane Database Syst Rev 9:CD008012

    PubMed  Google Scholar 

  • Benkert O (2009) StressDepression. Beck, München

    Google Scholar 

  • Blier P, Ward HE, Tremblay P et al (2010) Combination of antidepressant medications from treat- ment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 167(3): 281–288

    Google Scholar 

  • Chollet F, Tardy J, Albucher JF et al (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10(2):123–130

    Article  Google Scholar 

  • Cipriani A, Furukawa TA, Salanti G et al (2009a) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665): 746–758

    Article  Google Scholar 

  • Cipriani A, Santilli C, Furukawa TA et al (2009b) Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev 15(2): CD006532

    Google Scholar 

  • Dowlati Y, Herrmann N, Swardfager WL et al (2010) Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatry 55(2): 9

    Google Scholar 

  • Fournier JC, DeRubeis RJ, Hollon SD et al (2010) Antidepressant drug effects and depression sever- ity: a patient-level meta-analysis. JAMA 303(1): 47

    Article  PubMed  CAS  Google Scholar 

  • Gartlehner G, Hansen RA, Morgan LC et al (2011) Comparative benefits and harms of second- generation antidepressants for treating major depressive disorder: an updated meta-analy- sis. Ann Intern Med 155(11): 772–875

    Google Scholar 

  • Gibbons RD, Brown CH, Hur K et al (2012a) Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venla- faxine. Arch Gen Psychiatry. Epub ahead of print

    Google Scholar 

  • Gibbons RD, Hur K, Brown CH et al (2012b) Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxe- tine and venlafaxine. Arch Gen Psychiatry. Epub ahead of print

    Google Scholar 

  • Glassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66(9): 1022–1029

    Article  Google Scholar 

  • Gueorguieva R, Mallinckrodt C, Krystal JH (2011) Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. Arch Gen Psychiatry 68(12): 1227–1237

    Article  Google Scholar 

  • Hetrick SE, Purcell R, Garner B, Parslow R (2010) Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev (7): CD007316

    Google Scholar 

  • Hickie IB, Rogers NL (2011) Novel melatonin-based therapies: potential advances in the treatmentof major depression. Lancet 378(9791): 621–631

    Article  PubMed  CAS  Google Scholar 

  • Hiemke C, Baumann P, Bergemann N et al (2011) AGNP consensus guidelines for therapeutic drugmonitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6): 195–235

    Article  Google Scholar 

  • Jorge RE, Acion L, Moser D et al (2010) Escitalopram and enhancement of cognitive recoveryfollowing stroke. Arch Gen Psychiatry 67(2): 187–196

    Article  PubMed  Google Scholar 

  • Kellner CH, Knapp R, Husain MM et al (2010) Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 196(3): 226–234

    Article  Google Scholar 

  • Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepres- sants. J Affect Disord. Epub ahead of print

    Google Scholar 

  • Komossa K, Depping AM, Gaudchau A et al (2010). Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev 8(12): CD008121

    Google Scholar 

  • Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52(Suppl 5): 28–34

    PubMed  Google Scholar 

  • Labos C, Dasgupta K, Nedjar H et al (2011) Risk of bleeding associated, with combined use of selec- tive serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarc- tion. CMAJ 183(16): 1835–1843

    Article  PubMed  Google Scholar 

  • Leon AC, Solomon DA, Li C et al (2011) Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry 72(5): 580–586

    Google Scholar 

  • Levkovitz Y, Tedeschini E, Papakostas Gl (2011) Efficacy of antidepressants for dysthymia: a meta- analysis of lacebo-controlled randomized trials. J Clin Psychiatry 72(4): 509–514

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Devanand DP (2011) A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. J Am Geriatr Soc 59(4): 577–585

    Article  PubMed  Google Scholar 

  • Papakostas Gl, Mischoulon D, Shyu I et al (2010) S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant.nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J sychiatry 167(8): 942–948

    Google Scholar 

  • Posternak MA, Baer L, Nierenberg AA, Fava M (2011) Response rates to fluoxetine in subjects who initially show no improvement. J Clin Psychiatry 72(7): 949–954

    Article  Google Scholar 

  • Rush AJ, Trivedi MH, Wisniewski SR et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905–1917

    Article  PubMed  Google Scholar 

  • Rush AJ, Trivedi MH, Stewart JW et al (2011) Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 168(7): 689–701

    Article  Google Scholar 

  • Scherrer JF, Chrusciel T, Garfield LD et al (2012) Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry 200(2): 137–142

    Article  PubMed  Google Scholar 

  • Schneier FR, Neria Y, Pavlicova M et al (2012) Combined prolonged exposure therapy and parox- etine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry 169(1): 80–88

    PubMed  Google Scholar 

  • Schueler YB, Koesters M, Wieseler B et al (2011) A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Acta Psychiatr Scand 123(4): 247–265

    Article  Google Scholar 

  • Segal ZV, Bieling P, Young T et al (2010) Antidepressant monotherapy vs sequential pharmaco- therapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in re- current depression. Arch Gen Psychiatry 67(12): 1256–1264

    Article  Google Scholar 

  • Singh SP, Singh V, Kar N (2001) Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal. Int J Neuropsychopharmacol 23: 1–12

    Google Scholar 

  • Spielmans Gl, Berman MI, Usitalo AN (2011) Psychotherapy versus second-generation antidepressants in the treatment of depression: a meta-analysis. J Nerv Ment Dis 199(3): 142–149

    Article  PubMed  Google Scholar 

  • Stewart JA, Deliyannides DA, Hellerstein DJ et al (2011) Can people with nonsevere major depression benefit from antidepressant medication? J Clin Psychiatry 73(4): 518–525

    Article  PubMed  Google Scholar 

  • Sublette ME, Ellis SP, Geant AL, Mann JJ (2011) Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 72(12): 1577–1584

    Article  Google Scholar 

  • Tedeschini E, Levkovitz Y, Iovieno N et al (2011) Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychia- try 72(12): 1660–1668

    Article  CAS  Google Scholar 

  • Thase ME, Larsen KG, Kennedy SH (2011) Assessing the »true« effect of active antidepressant therapy vs. placebo in major depressive disorder: use of a mixture model. Br J Psychiatry 199(6): 501–507

    Article  Google Scholar 

  • Uher R, Mors O, Rietschel M et al (2011) Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J Clin Psychiatry 72(11): 1478–1484

    Article  Google Scholar 

  • Undurraga J, Baldessarini RJ (2012) Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 37(4): 851–864

    Article  PubMed  CAS  Google Scholar 

  • Valuck RJ, Orton HD, Libby AM (2209) Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry 70(8): 1069–1077

    Google Scholar 

  • Watanabe N, Omori IM, Nakagawa A et al (2011) Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev 12: CD006528

    PubMed  Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41): 687–693

    Google Scholar 

  • Wu CS, Wang SC, Cheng YC, Gau SS (2011) Association of cerebrovascular events with antidepres- sant use: a case-crossover study. Am J Psychiatry 168(5): 511–521

    Article  PubMed  Google Scholar 

  • Zobel I, Kech S, van Calker D et al (2011) Long-term effect of combined interpersonal psycho- therapy and pharmacotherapy in a randomized trial of depressed patients. Acta Psychiatr Scand 123(4): 276–282

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mainz

    Prof. Dr. med. Otto Benkert

  2. München

    Prof. Dr. med. Hanns Hippius

Authors
  1. Prof. Dr. med. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Hanns Hippius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O., Hippius, H. (2013). Antidepressiva. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29810-3_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29809-7

  • Online ISBN: 978-3-642-29810-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation